This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
The below stocks have been identified as having potential to register bigger than normal share price moves (up or down) today based on the news cited
AstraZeneca (AZN) - £10bn was wiped off the company's value yesterday as shares fell 15% yesterday following a drug failure in its key 'Mystic' study. The Pharmaceutical giant will be closely watched today.
Barclays (BARC) - Reports a £1.4bn attributable H1 loss as a further £700m of PPI provisions and the disposal of its Africa business weigh on incomes.
BT (BT.A) - Saw Q1 earnings fall 2% as it paid £225m to Deutsche Telekom and Orange, the former owners of its EE network, to avoid litigation as a result of the impact of the Italian accounting scandal continues.
International Consolidated Airlines (IAG) - The British Airways parent reported profits rose by 13.8% in H1, however non-fuel costs increased 3% as a result of the May power outage and revenue per seat also fell by 2.6%.
(Sources: Company Newswires, Bloomberg, FT, Reuters)
For more information on any of these individual news items, call into the trading floor
| Stock | Code | Close | High | Low |
| Anglo American | AAL | 3.2% | 5.4% | 2.5% |
| AstraZeneca | AZN | -15.4% | -12.0% | -16.7% |
| Lloyds | LLOY | -2.3% | 0.5% | -3.2% |
| Royal Bank of Scotland | RBS | -0.4% | 0.2% | -1.1% |
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research